| 摘要 |
The present invention relates to a combination of a selective PDE4 inhibitor, as defined herein, and an adrenergic beta2 receptor agonist for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease.
|
